摘要
目的观察双风池穴定向透药治疗后循环缺血性眩晕风痰上扰证的临床疗效。方法将70例后循环缺血性眩晕风痰上扰证患者采用随机数字表法分为对照组和治疗组,各35例。对照组予基础治疗联合甲磺酸倍他司汀片,每次6 mg,每日3次,饭后口服;治疗组予基础治疗联合双风池穴定向透药。2组均以2周为1个疗程,1个疗程后比较2组的临床疗效以及治疗前后的中医证候积分、欧洲眩晕量表(EEV)评分、国际眩晕障碍量表(DHI)评分。结果对照组总有效率为77.1%(27/35),治疗组为85.7%(30/35),2组比较差异有统计学意义(P<0.05);治疗后2组中医证候积分,EEV、DHI评分均明显降低,与同组治疗前比较差异均有统计学意义(P<0.05),且治疗组降低更明显,与对照组治疗后比较差异均有统计学意义(P<0.05)。结论双风池穴定向透药治疗后循环缺血性眩晕风痰上扰证疗效确切,能明显改善患者的临床症状,作用优于甲磺酸倍他司汀片,值得临床推广应用。
Objective To observe the clinical efficacy of bilateral Fengchi( GB 20) acupoint directional transdermal medication therapy in the treatment of posterior circulation ischemic vertigo( PCSV) with wind-phlegm disturbance syndrome. Methods Seventy cases of PCSV with wind-phlegm disturbance syndrome were divided into control group and treatment group according to random number table method,with 35 cases in each group. The control group was given basic treatment combined with betahistine mesilate tablets,6 mg per time,3 times a day,and was given orally after a meal. The treatment group was given basic treatment combined with bilateral Fengchi( GB20) acupoint directional transdermal medication therapy. Two weeks constituted 1 course of treatment for both groups. After 1 course of treatment,the clinical efficacy,TCM symptom scores,European evaluation vertigo( EEV)scale scores and international dizziness handicap inventory( DHI) scale scores before and after treatment between the 2 groups were compared. Results The total effective rate of the control group was 77.1%( 27/35),that of the treatment group was 85.7%( 30/35),and the difference between the 2 groups was statistically significant( P<0.05).After treatment,TCM symptom scores,EEV and DHI scores were significantly reduced in the 2 groups,and the difference was statistically significant compared with the same group before treatment( P<0.05),moreover,the treatment group decreased more significantly,and the difference was statistically significant compared with the control group after treatment( P<0.05).Conclusion It has definite efficacy and can markedly improve the clinical symptoms of the patients to use bilateral Fengchi( GB 20) acupoint directional transdermal medication therapy in the treatment of PCSV with wind-phlegm disturbance syndrome,whose effect is superior to that of betahistine mesilate tablets,which deserves clinical promotion and application.
作者
白瑞丽
BAI Ruili(The First District of Encephalopathy,Jiaozuo Hospital of TCM,Jiaozuo,Henan,454000,China)
出处
《甘肃中医药大学学报》
2021年第2期62-65,共4页
Journal of Gansu University of Chinese Medicine
关键词
后循环缺血性眩晕
风痰上扰证
风池穴
定向透药
甲磺酸倍他司汀片
中医证候积分
欧洲眩晕量表评分
国际眩晕障碍量表评分
临床疗效
posterior circulation ischemic vertigo(PCSV)
wind-phlegm disturbance syndrome
Fengchi(GB 20)acupoint
directional transdermal medication
betahistine mesilate tablets
TCM symptom scores
European evaluation vertigo(EEV)scale scores
international dizziness handicap inventory(DHI)scale scores
clinical efficacy
作者简介
白瑞丽(1985-),女,主治中医师,医学硕士,主要从事脑病的中西医诊治工作。
